Anti-cytoplasmic anti-bodies of neutrophils and monocytes - Appreciation of their use in clinical practise
Keywords:
vasculitis, Wegener, ANCA, PR3, MPOAbstract
Ten years passed over the discovery of ANCA - Antineutrophil Cytoplasmic Antibodies - without the criteria that stablish a clinicai relation concerning the study of the vasculitic sindromes. This article reviews the importance of ANCA in vasculitis, with special attention devoted to physiological, diagnostic and prognostic implications.
Downloads
References
Davies DJ, Moran JE. Niall JF. Segmental nccrotising glomerulonephritis with antineutrophil antibody· possible arbovirus aetiology? BMJ 1982; 285. 606.
Jennctte JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis 1990; 15: 517- 529.
Wieslander J. How are antineutrophil cytoplasmic autoantibodies detected? Am J Kidney Dis 1991; 18: 154-158.
Savige JA, Davies DJ, Gatenby PA. Antineutrophil cytoplasmic antibodies (ANCA): Their detection and significance: report from workshops. Pathology 1994; 26: 186-193.
Kallenberg et al. Antineutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney lnt. 1994; 46: 1-15.
John L, Niles MD. Antineutrophil cytoplasmic antibodies in lhe classification of vasculitis. Annu Rev Med 1996; 47: 303-313.
Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA et al. Autoantibodies against neutrophils and monocytes: too! for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancei 1985; 1: 425-429.
Nolle B, Specks U, Ludmann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic auto antibodies: their immunodiagnostic value in Wegner Granulomatosis. Ann lntern Med 1989; 111: 28-40.
Ulmer M, Rautmann A, Gross WL. lmmunodiagnostic aspects of autoantibodies against myeloperoxidase. Clin Nephrol 1992; J7: 161-168.
Guillevin L, Lhote F. Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol 1995; 7: 20-24.
Braun MG, Csernok E, Schmitt WH, Gross WL. lncidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in Reumatoid Arthritis. J Rheumatol 1996; 23: 826-830.
Homas PB, David-Bajar KM, Fitzpatrick JE et al. Microscopic Polyarteritis. Arch Dermatol 1992; 128: 1223-1228.
Niles JL, Bõttinger EP, Saurina GR et ai. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch lntern Med 1996; 156: 440-445.
Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, DeRemee RA. Anticytoplasmic autoantibodies in the diagnosis and follow up of Wegener's granulomatosis. Mayo Clin Proc 1989; 64: 28- 36.
Tervaert JWC, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, et ai. Association between aclive Wegener's granulomatosis and anticytoplasmic antibodies. Arch lntern Med 1989; 149: 2461-2465.
Gross WL, Schmitt WH, Csernok E. ANCA and associated d1seases: immunodiagnostic and pathogenetic aspects. Clin Exp lmmunol 1993; 93: 1-12.
Moder KG. Use and interpretation of Rheumatologic Tests: a guide for clinicians. Mayo Clin Proc 1996; 71: 391-396.
Davenport A. False positive perinuclear and cyloplasmic anti neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegwner's granulomatosis and/or microscopic polyarteritis. Clin Nephrol 1992; 37: 124-130.
DeClerck LS, Van Offel JF, Smolders WA, Empsten FA, Bridts CH, Bourgeois N et ai. Pitfalls with anti-neutrophil cytoplasmic antibodies (ANCA). Clin Rheumatol 1989; 8: 512-516.
Mustonen J, Soppi E, Pasternack A, Hallstrom O. Clinical significance of autoantibodies against neutrophil cytoplasmic components in patients with renal disease. Am J Nephrol 1990; 10: 482-488.
Andrassy K, Koderisch J, Rufer M, Erb A, Waldherr R, Ritz E. Detection and clinicai implication of anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis. Clin Nephrol 1989; 32: 159-167.
Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR. The role of antineutrophil cytoplasmic antibody (c ANCA) testing in the diagnosis of Wegener granulomatosis: a literature and meta-analysis. Ann lntern Med 1995; 123: 925-932.
Collins DA, Bourke BE. Antigen specificity of ANCA in systemic vasculitis. (letter) Br J Rheumatol 1995; 34: 394.
Falk RJ, Jennette J. Antineutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculllis and idiopathic and crescentic glomerulonephritis. N Engl J Med 1988; 318: 1651-1657.
Tervaert JWC, Goldschmeding R, Elema JD, Von Dem Borne AE, Kallenberg CG. Antimyeloperoxidase antibodies in lhe Churg Strauss syndrome. Thorax 199 I; 46: 70-71.
Kallenberg CGM, Mulder AHL, Tervaert JWC. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med 1992; 93: 675-681.
Lesavre P, Noel LH, Gayno S et ai. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (p-ANCA) specificity and clinical associations. J Autoimmunity 1993; 6: 185-195.
Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P. Persistence of antineutrophil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 1995; 13: 193-198.
Specks U, DeRemee RA. Granulomatous vasculitis, Wegener's granulomatosis and Churg-Strauss syndrome. Rheum Dis Clin North Am 1990; 16: 377-397.
Guillevin L, Visser H, Noel LH, Pourrat J, Vernier 1, Gayraud M, Oksman F, Lesavre P. Antineutrophil cytoplasm antibodies (ANCA) in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome. Sixty two patients. J Rheumatol I 993; 20: 1345-1349.
Geffriaud-Ricouard C, Noel LH, Chaveau D, Houhou S, Grunfeld JP, Lesavre P. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol 1993; 39: 125- I 36.
Falk RJ. ANCA-associated renal disease. kidney lnt 1990; 38: 998-1010.
Edgar JDM, McMillan SA, Bruce fN, Conlan SK. An audit of ANCA in routine clinicai practice. Postgrad Med J 1995; 71: 605- 612.
Tervaert JWC, Huitema MG, Hene RJ et ai. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancei 1990; 336: 709-711.
Saxon A, Shanchan F, Landers C et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin lmmunol I 990; 86: 202-210.
Rump JA, Scholmerich J, Gross V et ai. A new type of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in aclive Ulcerative Colitis but not in Crohn's disease. lmmunology 1990; 181: 406-413.
Feigenbaum PA, Medsger TA Jr, Kraines RG, Fries JF. The variability of immunologic laboratory tests. J Rheumatol 1982; 9: 408-414.
Unsworth DJ, Tomson CRV, Lock RJ, Wallington TB, Feest TG. e-ANCA as a marker of Wegener's disease. (letter) Lancet 1996; 347: 115-116.
Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS. Limited prognostic value of changes in antineutrophil cytoplasm antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 1993; 36: 365-371.
Hoffman GS, Kerr GS. Rise in ANCA titter: to treat or not to treat? (letter) Am J Med 1995; 98: 102-103.
Csernok E, Gross WL. lmmunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol 1995; 7:11-19.
Dolman KM, Stegeman CA, Van de Wiel BA, Hack CE, von dem Borne AEG, Kallenberg CGM, Goldschmeding R. Relevance of classic anti-neutrophil cytoplasmic autoantibody (c-ANCA) mediated inhibition of proteinase 3-alpha-1-antitrypsin complexation to disease activity in Wegener's granulomatosis. Clin Exp lmmunol 1993; 93: 405-410.
Mandell BF, Hoffman GS. Differentiating the vasculitides. Rheum Ois Clin North Am 1994; 20: 409-442.
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna
Open Access
